Late-life hemoglobin and the incidence of Parkinson's disease

Neurobiology of Aging

Volumn 33, Issue 5, 2012, Pages 914-920

  Abbott, Robert D ^a,b,c,d   Ross, G Webster ^b,c,d,e   Tanner, Caroline M ^f   Andersen, Julie K ^g   Masaki, Kamal H ^b,c,d   Rodriguez, Beatriz L ^b,c,d   White, Lon R ^b,c,d,e   Petrovitch, Helen ^b,c,d,e  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c KUAKINI MEDICAL CENTER   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e Department of Veteran's Affairs ^*  (United States)

^f PARKINSON S INSTITUTE   (United States)

^g BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Epidemiology; Hemoglobin; Iron; Parkinson's disease

Indexed keywords

HEMOGLOBIN;

AGE; AGED; ANEMIA; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; JAPANESE; MALE; MORTALITY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR;

AGE DISTRIBUTION; AGED; ASIAN AMERICANS; FOLLOW-UP STUDIES; HAWAII; HEMOGLOBINS; HEMOSIDEROSIS; HUMANS; INCIDENCE; MALE; NERVE DEGENERATION; PARKINSON DISEASE; RISK FACTORS;

EID: 84858342738     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.06.023     Document Type: Article

References (36)

1. Abbott R.D. Logistic regression in survival analysis. Am. J. Epidemiol 1985, 121:465-471.
2. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., Grandinetti A., Blanchette P.L., Popper J.S., Ross G.W. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57:456-462.
3. Abbott R.D., Ross G.W., White L.R., Tanner C.M., Masaki K.H., Nelson J.S., Curb J.D., Petrovitch H. Excessive daytime sleepiness and subsequent development of Parkinson's disease. Neurology 2005, 65:1442-1449.
4. Abbott R.D., Launer L.J., Rodriguez B.L., Ross G.W., Wilson P.W.F., Masaki K.H., Strozyk D., Curb J.D., Yano K., Popper J.S., Petrovitch H. Serum estradiol and risk of stroke in elderly men. Neurology 2007, 68:563-568.
5. Andre C., Truong T.T., Robert J.F., Guillaume Y.C. Effect of metals on herbicides-α-synuclein association: A possible factor in neurodegenerative disease studied by capillary electrophoresis. Electrophoresis 2005, 26:3256-3264.
6. Barbour R., Kling K., Anderson J.P., Banducci K., Cole T., Diep L., Fox M., Goldstein J.M., Soriano F., Seubert P., Chilcote T.J. Red blood cells are a major source of alpha-synuclein in blood. Neurodegener. Dis 2008, 5:55-59.
7. Bartzokis G., Tishler T.A., Shin I.S., Lu P.H., Cummings J.L. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. N. Y. Acad. Sci 2004, 1012:224-236.
8. Bartzokis G., Tishler T.A., Lu P.H., Villablanca P., Altshuler L.L., Carter M., Huang D., Edwards N., Mintz J. Brain ferritin iron may influence age- and gender related risks of neurodegeneration. Neurobiol. Aging 2007, 28:414-423.
9. Beard J.L., Connor J.R. Iron status and neural functioning. Annu. Rev. Nutr 2003, 23:41-58.
10. Bollinger P.B., Drewinko B., Brailas C.D., Smeeten N.A., Trujillo J.M. The technicon H*. 1 - an automated hematology analyzer for today and tomorrow: Complete blood cell parameters. Am. J. Clin. Pathol 1987, 87:71-78.
11. Cammack R., Shergill J.K., Ananda I.V., Hughes M.N. Applications of electron paramagnetic resonance spectroscopy to study interactions of iron proteins in cells with nitric oxide. Spectrochim. Acta A Mol. Biomol. Spectrosc 1998, 54A:2393-2402.
12. Chinta S.J., Kumar M.J., Hsu M., Rajagopalan S., Kaur D., Rane A., Nichols D.G., Choi J., Andersen J.K. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons results in nigrostriatal degeneration. J. Neurosci 2007, 25:13997-14006.
13. Costa-Mallen P., Checkoway H., Zabeti A., Edenfield M.J., Swanson P.D., Longstreth W.T., Franklin G.M., Smith-Weller T., Sadrzadeh S.M. The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet 2008, 147B:216-222.
14. Cox D.R. Regression models and life tables. J. R. Stat. Soc. (series B) 1972, 34:187-202.
15. Ferrucci L., Guralnik J.M., Bandinelli S., Semba R.D., Lauretani F., Corsi A., Ruggiero C., Ershler W.B., Longo D.L. Unexplained anaemia in older persons is characterized by low erythropoietin and low levels of pro-inflammatory markers. Br. J. Haematol 2007, 136:849-855.
16. Haaxma C.A., Bloem B.R., Borm G.F., Oyen W.J., Leeanders K.L., Eshuis S., Booji J., Dluzen D.E., Horstink M.W. Gender differences in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:819-824.
17. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem 1958, 3:41-51.
18. Kaur D., Andersen J. Does cellular iron dysregulation play a causative role in Parkinson's disease?. Age. Res. Rev 2004, 3:327-343.
19. Kaur D., Rajagopalan S., Andersen J.K. Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: Implications for Parkinson's disease. Brain Res 2009, 1297:17-22.
20. Lane P.W., Nelder J.A. Analysis of covariance and standardization as instances of prediction. Biometrics 1982, 38:613-621.
21. Logroscino G., Marder K., Graziano J., Freyer G., Slavkovich V., Lojacono N., Cote L., Mayeux R. Dietary iron, animal fats, and risk of Parkinson's disease. Mov. Disord 1998, 13(suppl 1):13-16.
22. Logroscino G., Gao X., Chen H., Wing A., Ascherio A. Dietary iron intake and risk of Parkinson's disease. Am. J. Epidemiol 2008, 168:1381-1388.
23. Mehta C.R., Patel N.R. Exact logistic regression: Theory and examples. Stat. Med 1995, 14:2143-2160.
24. Morens D.M., Davis J.W., Grandinetti A., Ross G.W., Popper J.S., White L.R. Epidemiologic observations on Parkinson's disease: Incidence and mortality in a prospective study of middle-aged men. Neurology 1996, 46:1044-1050.
25. Pinero D.J., Li N.Q., Connor J.R., Beard J.L. Variations in dietary iron alter brain iron metabolism in developing rats. J. Nutr 2000, 130:254-263.
26. Powers K.M., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D., Checkoway H. Parkinson's disease risk associated with dietary iron, manganese, and other nutrient intakes. Neurology 2003, 60:1761-1766.
27. Rhodes S.L., Ritz B. Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol. Dis 2008, 32:183-195.
28. Ross G.W., Abbott R.D., Petrovitch H., Morens D.M., Grandinetti A., Tung K.H., Tanner C.M., Masaki K.H., Blanchette P.L., Curb J.D., Popper J.S., White L.R. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000, 283:2674-2679.
29. Ross G.W., Petrovitch H., Abbott R.D., Nelson J., Markesbery W., Davis D., Hardman J., Launer L., Masaki K., Tanner C.M., White L.R. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann. Neurol 2004, 56:532-539.
30. Savica R., Grossardt B.R., Carlin J.M., Icen M., Bower J.H., Ahlskog J.E., Maraganore D.M., Steensma D.P., Rocca W.A. Anemia or low hemoglobin levels preceding Parkinson disease: A case-control study. Neurology 2009, 73:1381-1387.
31. Scherzer C.R., Grass J.A., Liao Z., Pepivani I., Zheng B., Eklund A.C., Ney P.A., Ng J., McGoldrick M., Mollenhauer B., Bresnick E.H., Schlossmacher M.G. GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10907-10912.
32. Shergill J.K., Cammack R., Cooper C.E., Cooper M., Mann V.M., Schapira A.H.V. Detection of nitrosyl complexes in human substantia nigra in relation to Parkinson's disease. Biochem. Biophys. Res. Commun 1996, 228:298-305.
33. Uversky V.N. Neuropathology, biochemistry, and biophysics of α-synuclein aggregation. J. Neurochem 2007, 103:17-37.
34. Ward C.D., Gibb W.R. Research diagnostic criteria for Parkinson's disease. Adv. Neurol 1990, 53:245-249.
35. White L., Petrovitch H., Ross G.W., Masaki K.H., Abbott R.D., Teng E.L., Rodriguez B.L., Blanchette P.L., Havlik R.J., Wergowske G., Chiu D., Foley D.J., Murdaugh C., Curb J.D. Prevalence of dementia in older Japanese-American men in Hawai'i: The Honolulu-Asia Aging Study. JAMA 1996, 276:955-960.
36. Wolozin B., Golts N. Iron and Parkinson's disease. Neuroscientist 2002, 8:22-32.